General form of registration statement for all companies including face-amount certificate companies

Secured Notes Payable (Details Textual)

v3.6.0.2
Secured Notes Payable (Details Textual)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 30, 2015
USD ($)
$ / shares
May 07, 2015
USD ($)
Investors
Apr. 23, 2015
USD ($)
Investors
Aug. 24, 2016
$ / shares
Mar. 31, 2016
USD ($)
shares
Feb. 29, 2016
USD ($)
shares
Nov. 30, 2015
USD ($)
Apr. 17, 2015
USD ($)
Investors
shares
Sep. 30, 2016
USD ($)
shares
Sep. 30, 2015
USD ($)
Sep. 30, 2016
USD ($)
$ / shares
shares
Sep. 30, 2015
USD ($)
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
Line of Credit Facility [Line Items]                            
Secured notes payable, description                         The conversion price for such Company Optional Redemption shall be a price equal to 100% of the Conversion Amount of the Notes being redeemed.  
Number of warrants issued for common stock | shares                     219,785      
Exercise price per share | $ / shares                     $ 12.50   $ 12.04  
Loss on exchange of warrants                 $ 279,000 $ 279,000
Amortization of debt discount                 $ 809,000 $ 1,117,000 $ 2,209,000 1,921,000    
Debt conversion amount                         500,000  
Fair value of embedded conversion feature liability                         $ 7,000  
Embedded conversion feature liability, description                         The Notes were issued with a feature that allows for up to 50% of the principal to be converted into our common stock. On December 30, 2015, the terms of the Notes were amended to allow the remaining 50% of the principal to be convertible into our common stock.  
Warrants exercisable term                     5 years      
Proceeds from issuance of common stock                     $ 2,883,000 $ 741,000 $ 3,125,000 $ 3,844,000
Percentage of principal amount of debt rereemed                     115.00%   115.00%  
Percentage of conversion outstanding amount                         100.00%  
Securities purchase agreement, description                     On April 11, 2016, we consummated a $3 million private offering and thereby satisfied condition (ii) above. On March 31, 2016 we issued the March Warrants, as described in Note 12, and we remained in compliance with the net monthly cash flow covenant listed in (iv) above during all relevant times. On June 29, 2016, we signed the CMLA, which will replace the CLA upon the successful completion of the technical tests associated with the KG2. Additionally, upon execution of the September Amendments (as defined below), the monthly cash flow covenant listed in (iv) above was removed.      
Fair value of additional warrants issued                     $ (3,124,000)   $ 205,000  
Issuance of warrant to investors | shares                 1,450,542   1,450,542   775,543  
Second Amendment Securities Purchase Agreement [Member]                            
Line of Credit Facility [Line Items]                            
Proceeds from issuance of common stock             $ 10,000,000              
Third Amendment Securities Purchase Agreement [Member]                            
Line of Credit Facility [Line Items]                            
Proceeds from issuance of common stock             $ 10,000,000              
Fourth Amendment Securities Purchase Agreement [Member]                            
Line of Credit Facility [Line Items]                            
Embedded conversion feature liability, description The December Amendments also amended the terms of the Notes to allow for the remaining 50% to be converted under the same terms as the original 50% as described above.                          
Percentage of conversion feature 50.00%                       100.00%  
Securities purchase agreement, description (i) extend the deadline to March 31, 2016 for the Company's consummation of a firm commitment underwritten public offering registered under the Securities Act and related listing of its Common Stock on a national securities exchange, (ii) provide for the issuance of additional five-year warrants (the "Additional Warrants"), exercisable for ten shares of Common Stock per $1,000 of outstanding principal of the 2015 Notes (defined below) held by each buyer pursuant to the April 2015 and May 2015 purchase agreements, each with an exercise price of $12.50 per share, subject to adjustment as set forth within the warrants, issuable in tranches triggered by certain Company actions as set forth in the December Amendments and (iii) authorize the Company, prior to January 31, 2016, to issue to one or more investors up to an aggregate of $1,000,000 principal amount of senior secured notes, on the terms and subject to the restrictions set forth in the December Amendments. An initial tranche of 50,000 Additional Warrants became issuable and were issued in conjunction with the execution of the December Amendments.                          
Fair value of beneficial conversion feature $ 609,000                          
Fair value of additional warrants issued $ 182,000                          
Fifth Amendment Securities Purchase Agreemen [Member]                            
Line of Credit Facility [Line Items]                            
Secured notes payable, description         (i) remove the requirement that the Company consummate a "Qualified Public Offering"; (ii) extend the deadline for the Company to commence trading on a Qualified Eligible Market (as defined in the March Amendments) to no later than April 14, 2016; provided that if the Company consummates a private offering of its securities resulting in gross proceeds to the Company of at least $3,000,000 after March 31, 2016 and prior to or on April 14, 2016 (a "Qualified Private Offering"), such deadline shall be automatically extended to October 15, 2016; (iii) provide for the issuance of the Additional Warrants, exercisable for ten shares of the Company's common stock per $100 of outstanding principal of the Senior Notes held by each buyer pursuant to the April 2015 and May 2015 Securities Purchase Agreements, each with an exercise price of $5.00 per share, subject to adjustment as set forth within the warrants; and (iv) add an additional covenant on behalf of the Company that, on or prior to April 14, 2016, it will cause its net monthly cash flow directly associated with the D-R Agreement , taken together with its monthly capital expenditure spending associated with the D-R Agreement , and excluding expenditures associated with the Full-Scale Acceptance Test ("FSAT") requirements defined in the D-R Agreement, to be neutral or positive, which may be accomplished by re-negotiation or termination of such D-R Agreement.                  
December 2015 Equity Offering [Member]                            
Line of Credit Facility [Line Items]                            
Issuance of warrant to investors | shares                         312,500  
Warrants [Member]                            
Line of Credit Facility [Line Items]                            
Proceeds recieved from debt gross                     $ 3,000,000      
Number of institutional investors | Investors               5            
Number of warrants issued for common stock | shares               81,942            
Common stock issued for exchange agreement | shares               73,747            
Exercise price per share | $ / shares       $ 4.00                    
Loss on exchange of warrants               $ 279,000            
Fair value of additional warrants issued         $ 1,497,000 $ 148,000                
Issuance of warrant to investors | shares         500,000 50,000                
Convertible Debt [Member]                            
Line of Credit Facility [Line Items]                            
Number of warrants issued for common stock | shares                         81,942  
Exercise price and grant date fair value | $ / shares $ 4.45                          
Risk free interest rate,maximum                         0.25%  
Risk free interest rate,minimum                         0.23%  
Volatility rate, Maximum                         148.00%  
Volatility rate, Minimum                         138.00%  
Expected life (in years) 4 months                       7 months  
Convertible debt combined value $ 609,000                       $ 611,000  
Debt conversion amount $ 2,500,000                       $ 2,500,000  
Embedded conversion feature liability, description The Company and the note holders amended the terms of the Notes to allow for the remaining 50% to be converted.                          
Percentage of conversion feature 50.00%                       50.00%  
Risk-free interest rate 0.48%                          
Volatility rate 107.00%                          
Convertible Debt [Member] | Maximum [Member]                            
Line of Credit Facility [Line Items]                            
Exercise price and grant date fair value | $ / shares                         $ 11.25  
Convertible Debt [Member] | Minimum [Member]                            
Line of Credit Facility [Line Items]                            
Exercise price and grant date fair value | $ / shares                         $ 11  
Secured Debt [Member]                            
Line of Credit Facility [Line Items]                            
Proceeds recieved from debt gross                     5,000,000      
Aggregate principal amount   $ 1,900,000 $ 3,100,000                      
Number of institutional investors | Investors   4 7                      
Transaction expenses                     $ 300,000   $ 300,000  
Bear interest rate                 12.00%   12.00%   12.00%  
Secured notes payable, description                     The 2015 Notes may be into shares of the Company's common stock. The 2015 Notes may be repaid by the Company at any time unless the 2015 Notes are in default.   The Notes become convertible at a price per share equal to 85% of the average of the five lowest volume weighted average prices of the Company's common stock during a 15 consecutive trading day period immediately prior to the applicable conversion date.  
Increased interest rate                     18.00%   18.00%  
Number of warrants issued for common stock | shares                         219,785  
Value of warrants issued                         $ 2,139,000  
Exercise price per share | $ / shares                         $ 12.50  
Debt instrument maturity description                     The 2015 Notes bear interest at a rate of 12% per year, payable monthly, and are set to mature on the two-year anniversary of the issuance dates of the 2015 Notes on April 23, 2017 and May 7, 2017 for the first and second tranches, respectively. Upon issuance of the 2015 Notes, each investor, at its discretion, was entitled to convert up to 50% of the balance outstanding under the 2015 Notes. Upon the execution of the December Amendments (as defined below), however, each investor became entitled to fully convert 100% of the balance outstanding under the 2015 Notes may be into shares of the Company's common stock. The 2015 Notes may be repaid by the Company at any time unless the 2015 Notes are in default.   The Notes bear interest at a rate of 12% per year, payable monthly, and are set to mature on the two year anniversary of the issuance dates of the Secured Notes on April 23, 2017 and May 7, 2017 for the first and second tranches, respectively. The Notes have a limited conversion feature. At the discretion of each investor, at issuance, 50% of the principal balance of the Notes, later amended to be 100% of the Notes may be exchanged for shares of the Company's common stock if the Company consummates a registered underwritten public offering of equity securities with aggregate gross offering proceeds of at least $10 million (the "Qualified Public Offering").  
Exercise price and grant date fair value | $ / shares                         $ 12.50  
Risk free interest rate,maximum                         1.02%  
Risk free interest rate,minimum                         0.87%  
Volatility rate, Maximum                         83.00%  
Volatility rate, Minimum                         78.00%  
Expected life (in years)                         5 years  
Amortization of debt discount                         $ 2,750,000  
Proceeds from secured note                     $ 5,000,000   $ 5,000,000  
Secured notes payable term                     2 years   2 years  
Warrants exercisable term                     5 years   5 years  
Proceeds from public offering                         $ 10,000,000  
Secured Debt [Member] | Private placement [Member]                            
Line of Credit Facility [Line Items]                            
Secured notes payable, description                         The Company agreed to pay the placement agent 5% of the aggregate principal amount of the Notes, which was paid at the closing date.  
Secured Debt [Member] | Maximum [Member]                            
Line of Credit Facility [Line Items]                            
Exercise price and grant date fair value | $ / shares                         $ 11.25  
Secured Debt [Member] | Minimum [Member]                            
Line of Credit Facility [Line Items]                            
Aggregate principal amount                         $ 5,000,000  
Exercise price and grant date fair value | $ / shares                         $ 11.00  
Offering Costs [Member]                            
Line of Credit Facility [Line Items]                            
Amortization of debt discount                         $ 303,000